Literature DB >> 7543331

Evaluating the cost of lasers for the treatment of benign prostatic hyperplasia.

C M Dixon1, C Theune.   

Abstract

Cost is an extremely complex equation with many variables, but itemized hospital bills are useful in analysis because they reflect costs as defined by an institution. Using this data source, we found that the total cost of an outpatient visual laser-assisted prostatectomy ($6,872.42) is almost the same as that of transurethral resection with a 3-day hospital stay ($6,925.00). Use of local anesthesia, improvement in the efficiency of tissue vaporization, and increases in fiber durability to permit multiple use would reduce laser prostatectomy costs. The true economic impact of laser prostatectomy awaits a long-term analysis that takes into account the costs of late complications and of reoperation.

Entities:  

Mesh:

Year:  1995        PMID: 7543331     DOI: 10.1089/end.1995.9.189

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  2 in total

1.  The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States.

Authors:  David A Taub; John T Wei
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

Review 2.  Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.

Authors:  H J Stoevelaar; J McDonnell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.